SLM + Axitinib for Clear Cell RCC

NCT02535533 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mohammed Milhem

Collaborators